Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tesch

Showing results (211-220 of 282) with videos related to

Pageof 29
Sort By:
Geburtshilfe Und Frauenheilkunde|July 14, 2015
Subcutaneous Trastuzumab for HER2-positive Breast Cancer - Evidence and Practical Experience in 7 German CentersC Jackisch, V Müller, P Dall, et al.
Nephrology (Carlton, Vic.)|March 12, 2004
Interferon-gamma induces macrophage migration inhibitory factor synthesis and secretion by tubular epithelial cellsEdwina K Rice, David J Nikolic-Paterson, Prudence A Hill, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG)V Diehl, M Loeffler, M Pfreundschuh, et al.
Leukemia|May 1, 1988
Ras mutations in Hodgkin's diseaseA C Steenvoorden, J W Janssen, H G Drexler, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 20, 2008
MKK3 signalling plays an essential role in leukocyte-mediated pancreatic injury in the multiple low-dose streptozotocin modelKyoichi Fukuda, Greg H Tesch, Felicia Y Yap, et al.
Leukemia & Lymphoma|March 18, 2000
Dexa-BEAM: an effective regimen for cytoreduction prior to high-dose chemotherapy with autologous stem cell support for patients with relapsed/refractory mantle-cell lymphomaA Josting, M Reiser, P D Wickramanayake, et al.
Journal of the American Society of Nephrology : JASN|January 23, 2003
Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritisCosimo Stambe, Robert C Atkins, Greg H Tesch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1998
Cytosine arabinoside, etoposide and aclarubicin (AVA) for the treatment of acute myeloid leukemia (AML) in elderly patientsP Staib, B Lathan, S Knöppel-Schwark, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2009
Pegylated liposomal doxorubicin (CAELYX) in patients with advanced ovarian cancer: results of a German multicenter observational studyJalid Sehouli, O Camara, M Schmidt, et al.
Endocrinology|June 3, 2016
Cardiac Tissue Injury and Remodeling Is Dependent Upon MR Regulation of Activation Pathways in Cardiac Tissue MacrophagesJimmy Z Shen, James Morgan, Greg H Tesch, et al.
Pageof 29

Showing results (211-220 of 282) with videos related to

Sort By:
Pageof 29
Geburtshilfe Und Frauenheilkunde|July 14, 2015
Subcutaneous Trastuzumab for HER2-positive Breast Cancer - Evidence and Practical Experience in 7 German CentersC Jackisch, V Müller, P Dall, et al.
Nephrology (Carlton, Vic.)|March 12, 2004
Interferon-gamma induces macrophage migration inhibitory factor synthesis and secretion by tubular epithelial cellsEdwina K Rice, David J Nikolic-Paterson, Prudence A Hill, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG)V Diehl, M Loeffler, M Pfreundschuh, et al.
Leukemia|May 1, 1988
Ras mutations in Hodgkin's diseaseA C Steenvoorden, J W Janssen, H G Drexler, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 20, 2008
MKK3 signalling plays an essential role in leukocyte-mediated pancreatic injury in the multiple low-dose streptozotocin modelKyoichi Fukuda, Greg H Tesch, Felicia Y Yap, et al.
Leukemia & Lymphoma|March 18, 2000
Dexa-BEAM: an effective regimen for cytoreduction prior to high-dose chemotherapy with autologous stem cell support for patients with relapsed/refractory mantle-cell lymphomaA Josting, M Reiser, P D Wickramanayake, et al.
Journal of the American Society of Nephrology : JASN|January 23, 2003
Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritisCosimo Stambe, Robert C Atkins, Greg H Tesch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1998
Cytosine arabinoside, etoposide and aclarubicin (AVA) for the treatment of acute myeloid leukemia (AML) in elderly patientsP Staib, B Lathan, S Knöppel-Schwark, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2009
Pegylated liposomal doxorubicin (CAELYX) in patients with advanced ovarian cancer: results of a German multicenter observational studyJalid Sehouli, O Camara, M Schmidt, et al.
Endocrinology|June 3, 2016
Cardiac Tissue Injury and Remodeling Is Dependent Upon MR Regulation of Activation Pathways in Cardiac Tissue MacrophagesJimmy Z Shen, James Morgan, Greg H Tesch, et al.
Pageof 29